Position in TMO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,166,664
-$6,126 QoQ
Shares Held
2,327
-2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#1,373
of 2,606 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fairscale Capital, LLC holds $1,487,293 across 7 Diagnostics & Research names. TMO ranks #1 (78.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
2,327 | $1,166,664 | |
| 2 | DHR |
Danaher Corp /De/
|
1,311 | $249,719 | |
| 3 | LH |
Labcorp Holdings Inc.
|
166 | $46,480 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
25 | $13,239 | |
| 5 | NTRA |
Natera, Inc.
|
34 | $9,229 | |
| 6 | ILMN |
Illumina, Inc.
|
10 | $1,758 | |
| 7 | GRAL |
GRAIL, Inc.
|
3 | $204 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,166,664 | 2,327 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,172,790 | 2,386 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,406,325 | 2,427 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,173,748 | 2,420 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $981,213 | 2,420 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,220,612 | 2,453 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,269,361 | 2,440 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,509,310 | 2,440 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,368,675 | 2,475 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||